Cargando…

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry

BACKGROUND: As mortality from pulmonary embolism (PE) decreases, the personal and societal costs among survivors are receiving increasing attention. Detailing this burden would support an efficient public health resource allocation. We aimed to provide estimates for the economic and disease burden o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farmakis, Ioannis T., Barco, Stefano, Mavromanoli, Anna C., Agnelli, Giancarlo, Cohen, Alexander T., Giannakoulas, George, Mahan, Charles E., Konstantinides, Stavros V., Valerio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673678/ https://www.ncbi.nlm.nih.gov/pubmed/36250664 http://dx.doi.org/10.1161/JAHA.122.027514

Ejemplares similares

Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

The management of acute venous thromboembolism in clinical practice: Results from the European PREFER in VTE Registry
por: Cohen, Alexander T., et al.
Publicado: (2017)

The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
por: Agnelli, Giancarlo, et al.
Publicado: (2015)

Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis
por: Hobohm, Lukas, et al.
Publicado: (2022)

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
por: Mavromanoli, Anna C., et al.
Publicado: (2021)

Pulmonary Embolism and Pregnancy—Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients
por: Hobohm, Lukas, et al.
Publicado: (2022)

Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
por: Voci, Davide, et al.
Publicado: (2022)

COVID-19 infection and its impact on case fatality in patients with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2023)

Pulmonary Embolism: Contemporary Medical Management and Future Perspectives
por: Barco, Stefano, et al.
Publicado: (2018)

Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Catheter-directed thrombolysis for acute pulmonary embolism: Where do we stand?
por: Barco, Stefano, et al.
Publicado: (2017)

Diagnostik und Therapie der Lungenembolie
por: Konstantinides, Stavros, et al.
Publicado: (2021)

Erratum zu: Diagnostik und Therapie der Lungenembolie
por: Konstantinides, Stavros, et al.
Publicado: (2022)

VTE Registry: What Can Be Learned from RIETE?
por: Tzoran, Inna, et al.
Publicado: (2014)

Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
por: Roncon, Loris, et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study
por: Klok, Frederikus A., et al.
Publicado: (2018)

Percutaneous thrombectomy in patients with intermediate- and high-risk pulmonary embolism and contraindications to thrombolytics: a systematic review and meta-analysis
por: Milioglou, Ioannis, et al.
Publicado: (2022)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
por: Cohen, Alexander T., et al.
Publicado: (2018)

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
por: Cohen, Alexander T., et al.
Publicado: (2018)

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
por: Mavromanoli, Anna C., et al.
Publicado: (2022)

Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis
por: Roncon, Loris, et al.
Publicado: (2020)

Predisposing factors for admission to intensive care units of patients with COVID-19 infection—Results of the German nationwide inpatient sample
por: Keller, Karsten, et al.
Publicado: (2023)

Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry)
por: Ohashi, Yasuo, et al.
Publicado: (2018)

Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2020)

Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2023)

Recommendations for VTE Prophylaxis in Medically Ill Patients
por: Skeik, Nedaa, et al.
Publicado: (2020)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
por: Ohsumi, Shozo, et al.
Publicado: (2023)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
por: Yoshikawa, Takaki, et al.
Publicado: (2023)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
por: Okusaka, Takuji, et al.
Publicado: (2023)

Development and Validation of a Prediction Model for Venous Thrombus Embolism (VTE) in Patients With Colorectal Cancer
por: Tan, Wei-Juan, et al.
Publicado: (2023)

Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis
por: Barco, Stefano, et al.
Publicado: (2019)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)
por: Ikeda, Masataka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5aginb3aoh7q0ljeo6g2q9bq28